Results 151 to 160 of about 22,534,193 (360)

Guiding principles for health equity in oncology: insights from patient organizations from the Middle East and Africa

Frontiers in Health Services
This paper explores the role of patient advocacy in fostering patient-centered care (PCC), empowerment, and equitable access to healthcare in the Middle East and Africa (MEA) region.
Sawsan Al-Madhi, Lauren Pretorius, Emad Shash, Emad Shash, Belma Kurdoglu, Ahmad Rabea, Ahmad Rabea, Ahmad Rabea, Atlal Abusanad, Hani Nassar, Hamida Kettab, Benda Kithaka, Khaled Abdel Aziz   +12 more
doaj   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

ATNEC – Patient Experience Sub-Study (IRSCTN: 36585784): What Patients Think About Taking Part In Breast Cancer Treatment De-Escalation Trials?

Breast, 2023
Janet A. Dunn, Sophie Gasson, Sophie Nicholls, Jan Rose, Helen Teresa Edwards, Andrea Marshall, Natalie Hammonds, Beatrix Elsberger, Amit Goyal   +8 more
doaj   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Rákos betegek mentális és lelki kísérése

Studia Universitatis Babeş-Bolyai. Theologia Reformata Transylvanica
Mental and Spiritual Accompaniment of Cancer Patients This paper explores the mental and spiritual accompaniment of cancer patients from a theological and pastoral perspective.
Gyöngyi BALOGH
doaj   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

The Role of Registered Dietitians in Cancer Palliative Care: Responsibilities, Challenges, and Interdisciplinary Collaboration—A Cross-Sectional Survey

Current Oncology
Registered dietitians (RDs) in palliative care help maintain patients’ quality of life by providing personalized nutritional support that alleviates eating-related distress.
Saori Koshimoto, Koji Amano, Naoharu Mori, Atsuko Imai, Manami Sasaki, Miho Miyajima, Takashi Takeuchi   +6 more
doaj   +1 more source

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Nature, 2014
Roy S. Herbst, J. Soria, M. Kowanetz, G. Fine, O. Hamid, M. Gordon, Jeffery A. Sosman, David F. McDermott, J. Powderly, S. Gettinger, H. Kohrt, L. Horn, Donald P. Lawrence, S. Rost, M. Leabman, Yuanyuan Xiao, A. Mokatrin, H. Koeppen, P. Hegde, I. Mellman, Daniel S. Chen, F. Hodi   +21 more
semanticscholar   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Patients With Cancer

Clinical and Applied Thrombosis/Hemostasis, 2013
A. Nicolaides, J. Fareed, A. K. Kakkar, A. J. Comerota, S. Z. Goldhaber, R. Hull, K. Myers, M. Samama, J. Fletcher, E. Kalodiki, D. Bergqvist, J. Bonnar, J. A. Caprini, C. Carter, J. Conard, B. Eklof, I. Elalamy, G. Gerotziafas, G. Geroulakos, A. Giannoukas, I. Greer, M. Griffin, S. Kakkos, M. R. Lassen, G. D. O. Lowe, A. Markel, P. Prandoni, G. Raskob, A. C. Spyropoulos, A. G. Turpie, J. M. Walenga, D. Warwick   +31 more
openaire   +2 more sources